nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—TOP2A—Epirubicin—pancreatic cancer	0.188	0.282	CbGbCtD
Levofloxacin—TOP2A—Doxorubicin—pancreatic cancer	0.0999	0.15	CbGbCtD
Levofloxacin—CYP1A2—Dacarbazine—pancreatic cancer	0.0458	0.0686	CbGbCtD
Levofloxacin—CYP1A2—Tamoxifen—pancreatic cancer	0.0364	0.0546	CbGbCtD
Levofloxacin—ABCB1—Tamoxifen—pancreatic cancer	0.0319	0.0477	CbGbCtD
Levofloxacin—CYP1A2—Erlotinib—pancreatic cancer	0.031	0.0464	CbGbCtD
Levofloxacin—ABCB1—Gemcitabine—pancreatic cancer	0.0275	0.0411	CbGbCtD
Levofloxacin—ABCB1—Erlotinib—pancreatic cancer	0.0271	0.0406	CbGbCtD
Levofloxacin—CYP1A2—Fluorouracil—pancreatic cancer	0.0269	0.0402	CbGbCtD
Levofloxacin—ABCB1—Irinotecan—pancreatic cancer	0.0245	0.0367	CbGbCtD
Levofloxacin—CYP3A4—Tamoxifen—pancreatic cancer	0.0191	0.0286	CbGbCtD
Levofloxacin—ABCB1—Docetaxel—pancreatic cancer	0.0179	0.0269	CbGbCtD
Levofloxacin—ABCB1—Sunitinib—pancreatic cancer	0.0179	0.0267	CbGbCtD
Levofloxacin—CYP3A4—Erlotinib—pancreatic cancer	0.0162	0.0243	CbGbCtD
Levofloxacin—CYP3A4—Irinotecan—pancreatic cancer	0.0147	0.022	CbGbCtD
Levofloxacin—ABCB1—Doxorubicin—pancreatic cancer	0.0134	0.02	CbGbCtD
Levofloxacin—CYP3A4—Docetaxel—pancreatic cancer	0.0107	0.0161	CbGbCtD
Levofloxacin—CYP3A4—Sunitinib—pancreatic cancer	0.0107	0.016	CbGbCtD
Levofloxacin—CYP3A4—Doxorubicin—pancreatic cancer	0.00801	0.012	CbGbCtD
Levofloxacin—TOP2A—Topotecan—Irinotecan—pancreatic cancer	0.00141	0.24	CbGdCrCtD
Levofloxacin—TOP2A—Paclitaxel—Docetaxel—pancreatic cancer	0.000993	0.168	CbGdCrCtD
Levofloxacin—TOP2A—Gefitinib—Erlotinib—pancreatic cancer	0.000953	0.162	CbGdCrCtD
Levofloxacin—TOP2A—Cytarabine—Gemcitabine—pancreatic cancer	0.000359	0.0608	CbGdCrCtD
Levofloxacin—TOP2A—Idarubicin—Epirubicin—pancreatic cancer	0.000333	0.0564	CbGdCrCtD
Levofloxacin—TOP2A—Daunorubicin—Epirubicin—pancreatic cancer	0.000333	0.0564	CbGdCrCtD
Levofloxacin—TOP2A—Doxorubicin—Epirubicin—pancreatic cancer	0.000333	0.0564	CbGdCrCtD
Levofloxacin—TOP2A—Idarubicin—Doxorubicin—pancreatic cancer	0.000308	0.0522	CbGdCrCtD
Levofloxacin—TOP2A—Epirubicin—Doxorubicin—pancreatic cancer	0.000308	0.0522	CbGdCrCtD
Levofloxacin—TOP2A—Daunorubicin—Doxorubicin—pancreatic cancer	0.000308	0.0522	CbGdCrCtD
Levofloxacin—TOP2A—Azacitidine—Gemcitabine—pancreatic cancer	0.000257	0.0436	CbGdCrCtD
Levofloxacin—Weight decreased—Doxorubicin—pancreatic cancer	9.09e-05	0.000278	CcSEcCtD
Levofloxacin—Sinusitis—Epirubicin—pancreatic cancer	9.08e-05	0.000278	CcSEcCtD
Levofloxacin—Hyperglycaemia—Doxorubicin—pancreatic cancer	9.06e-05	0.000277	CcSEcCtD
Levofloxacin—Diarrhoea—Irinotecan—pancreatic cancer	9.06e-05	0.000277	CcSEcCtD
Levofloxacin—Agranulocytosis—Epirubicin—pancreatic cancer	9.03e-05	0.000277	CcSEcCtD
Levofloxacin—Pneumonia—Doxorubicin—pancreatic cancer	9.01e-05	0.000276	CcSEcCtD
Levofloxacin—Shock—Docetaxel—pancreatic cancer	9e-05	0.000276	CcSEcCtD
Levofloxacin—Nervous system disorder—Docetaxel—pancreatic cancer	8.97e-05	0.000275	CcSEcCtD
Levofloxacin—Pruritus—Fluorouracil—pancreatic cancer	8.97e-05	0.000275	CcSEcCtD
Levofloxacin—Thrombocytopenia—Docetaxel—pancreatic cancer	8.96e-05	0.000274	CcSEcCtD
Levofloxacin—Infestation NOS—Doxorubicin—pancreatic cancer	8.95e-05	0.000274	CcSEcCtD
Levofloxacin—Infestation—Doxorubicin—pancreatic cancer	8.95e-05	0.000274	CcSEcCtD
Levofloxacin—Drowsiness—Doxorubicin—pancreatic cancer	8.95e-05	0.000274	CcSEcCtD
Levofloxacin—Tachycardia—Docetaxel—pancreatic cancer	8.93e-05	0.000273	CcSEcCtD
Levofloxacin—Skin disorder—Docetaxel—pancreatic cancer	8.89e-05	0.000272	CcSEcCtD
Levofloxacin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	8.88e-05	0.000272	CcSEcCtD
Levofloxacin—Bradycardia—Epirubicin—pancreatic cancer	8.84e-05	0.000271	CcSEcCtD
Levofloxacin—Diarrhoea—Gemcitabine—pancreatic cancer	8.82e-05	0.00027	CcSEcCtD
Levofloxacin—Renal failure—Doxorubicin—pancreatic cancer	8.8e-05	0.00027	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	8.78e-05	0.000269	CcSEcCtD
Levofloxacin—Dizziness—Irinotecan—pancreatic cancer	8.75e-05	0.000268	CcSEcCtD
Levofloxacin—Haemoglobin—Epirubicin—pancreatic cancer	8.73e-05	0.000267	CcSEcCtD
Levofloxacin—Jaundice—Doxorubicin—pancreatic cancer	8.73e-05	0.000267	CcSEcCtD
Levofloxacin—Stomatitis—Doxorubicin—pancreatic cancer	8.73e-05	0.000267	CcSEcCtD
Levofloxacin—Anorexia—Docetaxel—pancreatic cancer	8.72e-05	0.000267	CcSEcCtD
Levofloxacin—Rhinitis—Epirubicin—pancreatic cancer	8.71e-05	0.000267	CcSEcCtD
Levofloxacin—Conjunctivitis—Doxorubicin—pancreatic cancer	8.7e-05	0.000267	CcSEcCtD
Levofloxacin—Hepatitis—Epirubicin—pancreatic cancer	8.69e-05	0.000266	CcSEcCtD
Levofloxacin—Haemorrhage—Epirubicin—pancreatic cancer	8.69e-05	0.000266	CcSEcCtD
Levofloxacin—Diarrhoea—Fluorouracil—pancreatic cancer	8.67e-05	0.000266	CcSEcCtD
Levofloxacin—Hypoaesthesia—Epirubicin—pancreatic cancer	8.64e-05	0.000265	CcSEcCtD
Levofloxacin—Pharyngitis—Epirubicin—pancreatic cancer	8.62e-05	0.000264	CcSEcCtD
Levofloxacin—Urinary tract disorder—Epirubicin—pancreatic cancer	8.58e-05	0.000263	CcSEcCtD
Levofloxacin—Oedema peripheral—Epirubicin—pancreatic cancer	8.56e-05	0.000262	CcSEcCtD
Levofloxacin—Hypotension—Docetaxel—pancreatic cancer	8.55e-05	0.000262	CcSEcCtD
Levofloxacin—Haematuria—Doxorubicin—pancreatic cancer	8.54e-05	0.000261	CcSEcCtD
Levofloxacin—Connective tissue disorder—Epirubicin—pancreatic cancer	8.54e-05	0.000261	CcSEcCtD
Levofloxacin—Urethral disorder—Epirubicin—pancreatic cancer	8.52e-05	0.000261	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	8.47e-05	0.000259	CcSEcCtD
Levofloxacin—Epistaxis—Doxorubicin—pancreatic cancer	8.45e-05	0.000259	CcSEcCtD
Levofloxacin—Vomiting—Irinotecan—pancreatic cancer	8.42e-05	0.000258	CcSEcCtD
Levofloxacin—Sinusitis—Doxorubicin—pancreatic cancer	8.4e-05	0.000257	CcSEcCtD
Levofloxacin—Dizziness—Fluorouracil—pancreatic cancer	8.38e-05	0.000257	CcSEcCtD
Levofloxacin—Visual impairment—Epirubicin—pancreatic cancer	8.37e-05	0.000256	CcSEcCtD
Levofloxacin—Agranulocytosis—Doxorubicin—pancreatic cancer	8.36e-05	0.000256	CcSEcCtD
Levofloxacin—Rash—Irinotecan—pancreatic cancer	8.35e-05	0.000256	CcSEcCtD
Levofloxacin—Dermatitis—Irinotecan—pancreatic cancer	8.34e-05	0.000255	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	8.34e-05	0.000255	CcSEcCtD
Levofloxacin—Headache—Irinotecan—pancreatic cancer	8.29e-05	0.000254	CcSEcCtD
Levofloxacin—Insomnia—Docetaxel—pancreatic cancer	8.28e-05	0.000253	CcSEcCtD
Levofloxacin—Paraesthesia—Docetaxel—pancreatic cancer	8.22e-05	0.000252	CcSEcCtD
Levofloxacin—Erythema multiforme—Epirubicin—pancreatic cancer	8.21e-05	0.000252	CcSEcCtD
Levofloxacin—Vomiting—Gemcitabine—pancreatic cancer	8.2e-05	0.000251	CcSEcCtD
Levofloxacin—Bradycardia—Doxorubicin—pancreatic cancer	8.18e-05	0.000251	CcSEcCtD
Levofloxacin—Dyspnoea—Docetaxel—pancreatic cancer	8.16e-05	0.00025	CcSEcCtD
Levofloxacin—Somnolence—Docetaxel—pancreatic cancer	8.13e-05	0.000249	CcSEcCtD
Levofloxacin—Rash—Gemcitabine—pancreatic cancer	8.13e-05	0.000249	CcSEcCtD
Levofloxacin—Dermatitis—Gemcitabine—pancreatic cancer	8.12e-05	0.000249	CcSEcCtD
Levofloxacin—Eye disorder—Epirubicin—pancreatic cancer	8.12e-05	0.000249	CcSEcCtD
Levofloxacin—Tinnitus—Epirubicin—pancreatic cancer	8.1e-05	0.000248	CcSEcCtD
Levofloxacin—Haemoglobin—Doxorubicin—pancreatic cancer	8.08e-05	0.000247	CcSEcCtD
Levofloxacin—Headache—Gemcitabine—pancreatic cancer	8.08e-05	0.000247	CcSEcCtD
Levofloxacin—Flushing—Epirubicin—pancreatic cancer	8.06e-05	0.000247	CcSEcCtD
Levofloxacin—Cardiac disorder—Epirubicin—pancreatic cancer	8.06e-05	0.000247	CcSEcCtD
Levofloxacin—Vomiting—Fluorouracil—pancreatic cancer	8.06e-05	0.000247	CcSEcCtD
Levofloxacin—Rhinitis—Doxorubicin—pancreatic cancer	8.06e-05	0.000247	CcSEcCtD
Levofloxacin—Dyspepsia—Docetaxel—pancreatic cancer	8.05e-05	0.000247	CcSEcCtD
Levofloxacin—Hepatitis—Doxorubicin—pancreatic cancer	8.04e-05	0.000246	CcSEcCtD
Levofloxacin—Haemorrhage—Doxorubicin—pancreatic cancer	8.04e-05	0.000246	CcSEcCtD
Levofloxacin—Hypoaesthesia—Doxorubicin—pancreatic cancer	8e-05	0.000245	CcSEcCtD
Levofloxacin—Rash—Fluorouracil—pancreatic cancer	7.99e-05	0.000245	CcSEcCtD
Levofloxacin—Dermatitis—Fluorouracil—pancreatic cancer	7.99e-05	0.000245	CcSEcCtD
Levofloxacin—Pharyngitis—Doxorubicin—pancreatic cancer	7.98e-05	0.000244	CcSEcCtD
Levofloxacin—Decreased appetite—Docetaxel—pancreatic cancer	7.95e-05	0.000244	CcSEcCtD
Levofloxacin—Headache—Fluorouracil—pancreatic cancer	7.94e-05	0.000243	CcSEcCtD
Levofloxacin—Urinary tract disorder—Doxorubicin—pancreatic cancer	7.94e-05	0.000243	CcSEcCtD
Levofloxacin—Oedema peripheral—Doxorubicin—pancreatic cancer	7.92e-05	0.000242	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	7.9e-05	0.000242	CcSEcCtD
Levofloxacin—Connective tissue disorder—Doxorubicin—pancreatic cancer	7.9e-05	0.000242	CcSEcCtD
Levofloxacin—Fatigue—Docetaxel—pancreatic cancer	7.89e-05	0.000242	CcSEcCtD
Levofloxacin—Angiopathy—Epirubicin—pancreatic cancer	7.88e-05	0.000241	CcSEcCtD
Levofloxacin—Urethral disorder—Doxorubicin—pancreatic cancer	7.88e-05	0.000241	CcSEcCtD
Levofloxacin—Nausea—Irinotecan—pancreatic cancer	7.86e-05	0.000241	CcSEcCtD
Levofloxacin—Immune system disorder—Epirubicin—pancreatic cancer	7.85e-05	0.00024	CcSEcCtD
Levofloxacin—Mediastinal disorder—Epirubicin—pancreatic cancer	7.83e-05	0.00024	CcSEcCtD
Levofloxacin—Pain—Docetaxel—pancreatic cancer	7.83e-05	0.00024	CcSEcCtD
Levofloxacin—Constipation—Docetaxel—pancreatic cancer	7.83e-05	0.00024	CcSEcCtD
Levofloxacin—Chills—Epirubicin—pancreatic cancer	7.79e-05	0.000239	CcSEcCtD
Levofloxacin—Arrhythmia—Epirubicin—pancreatic cancer	7.76e-05	0.000238	CcSEcCtD
Levofloxacin—Visual impairment—Doxorubicin—pancreatic cancer	7.75e-05	0.000237	CcSEcCtD
Levofloxacin—Alopecia—Epirubicin—pancreatic cancer	7.68e-05	0.000235	CcSEcCtD
Levofloxacin—Nausea—Gemcitabine—pancreatic cancer	7.66e-05	0.000235	CcSEcCtD
Levofloxacin—Mental disorder—Epirubicin—pancreatic cancer	7.61e-05	0.000233	CcSEcCtD
Levofloxacin—Erythema multiforme—Doxorubicin—pancreatic cancer	7.6e-05	0.000233	CcSEcCtD
Levofloxacin—Malnutrition—Epirubicin—pancreatic cancer	7.56e-05	0.000232	CcSEcCtD
Levofloxacin—Erythema—Epirubicin—pancreatic cancer	7.56e-05	0.000232	CcSEcCtD
Levofloxacin—Feeling abnormal—Docetaxel—pancreatic cancer	7.54e-05	0.000231	CcSEcCtD
Levofloxacin—Nausea—Fluorouracil—pancreatic cancer	7.53e-05	0.000231	CcSEcCtD
Levofloxacin—Eye disorder—Doxorubicin—pancreatic cancer	7.51e-05	0.00023	CcSEcCtD
Levofloxacin—Tinnitus—Doxorubicin—pancreatic cancer	7.49e-05	0.00023	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Docetaxel—pancreatic cancer	7.48e-05	0.000229	CcSEcCtD
Levofloxacin—Flushing—Doxorubicin—pancreatic cancer	7.46e-05	0.000228	CcSEcCtD
Levofloxacin—Cardiac disorder—Doxorubicin—pancreatic cancer	7.46e-05	0.000228	CcSEcCtD
Levofloxacin—Flatulence—Epirubicin—pancreatic cancer	7.45e-05	0.000228	CcSEcCtD
Levofloxacin—Tension—Epirubicin—pancreatic cancer	7.42e-05	0.000227	CcSEcCtD
Levofloxacin—Dysgeusia—Epirubicin—pancreatic cancer	7.41e-05	0.000227	CcSEcCtD
Levofloxacin—Nervousness—Epirubicin—pancreatic cancer	7.35e-05	0.000225	CcSEcCtD
Levofloxacin—Back pain—Epirubicin—pancreatic cancer	7.32e-05	0.000224	CcSEcCtD
Levofloxacin—Angiopathy—Doxorubicin—pancreatic cancer	7.29e-05	0.000223	CcSEcCtD
Levofloxacin—Muscle spasms—Epirubicin—pancreatic cancer	7.27e-05	0.000223	CcSEcCtD
Levofloxacin—Immune system disorder—Doxorubicin—pancreatic cancer	7.26e-05	0.000222	CcSEcCtD
Levofloxacin—Mediastinal disorder—Doxorubicin—pancreatic cancer	7.24e-05	0.000222	CcSEcCtD
Levofloxacin—Abdominal pain—Docetaxel—pancreatic cancer	7.23e-05	0.000222	CcSEcCtD
Levofloxacin—Body temperature increased—Docetaxel—pancreatic cancer	7.23e-05	0.000222	CcSEcCtD
Levofloxacin—Chills—Doxorubicin—pancreatic cancer	7.21e-05	0.000221	CcSEcCtD
Levofloxacin—Arrhythmia—Doxorubicin—pancreatic cancer	7.18e-05	0.00022	CcSEcCtD
Levofloxacin—Vision blurred—Epirubicin—pancreatic cancer	7.13e-05	0.000218	CcSEcCtD
Levofloxacin—Alopecia—Doxorubicin—pancreatic cancer	7.1e-05	0.000218	CcSEcCtD
Levofloxacin—Mental disorder—Doxorubicin—pancreatic cancer	7.04e-05	0.000216	CcSEcCtD
Levofloxacin—Ill-defined disorder—Epirubicin—pancreatic cancer	7.02e-05	0.000215	CcSEcCtD
Levofloxacin—Malnutrition—Doxorubicin—pancreatic cancer	7e-05	0.000214	CcSEcCtD
Levofloxacin—Erythema—Doxorubicin—pancreatic cancer	7e-05	0.000214	CcSEcCtD
Levofloxacin—Anaemia—Epirubicin—pancreatic cancer	6.99e-05	0.000214	CcSEcCtD
Levofloxacin—Agitation—Epirubicin—pancreatic cancer	6.95e-05	0.000213	CcSEcCtD
Levofloxacin—Flatulence—Doxorubicin—pancreatic cancer	6.9e-05	0.000211	CcSEcCtD
Levofloxacin—Tension—Doxorubicin—pancreatic cancer	6.87e-05	0.00021	CcSEcCtD
Levofloxacin—Dysgeusia—Doxorubicin—pancreatic cancer	6.85e-05	0.00021	CcSEcCtD
Levofloxacin—Malaise—Epirubicin—pancreatic cancer	6.82e-05	0.000209	CcSEcCtD
Levofloxacin—Nervousness—Doxorubicin—pancreatic cancer	6.8e-05	0.000208	CcSEcCtD
Levofloxacin—Vertigo—Epirubicin—pancreatic cancer	6.79e-05	0.000208	CcSEcCtD
Levofloxacin—Syncope—Epirubicin—pancreatic cancer	6.78e-05	0.000208	CcSEcCtD
Levofloxacin—Leukopenia—Epirubicin—pancreatic cancer	6.77e-05	0.000207	CcSEcCtD
Levofloxacin—Back pain—Doxorubicin—pancreatic cancer	6.77e-05	0.000207	CcSEcCtD
Levofloxacin—Hypersensitivity—Docetaxel—pancreatic cancer	6.74e-05	0.000206	CcSEcCtD
Levofloxacin—Muscle spasms—Doxorubicin—pancreatic cancer	6.73e-05	0.000206	CcSEcCtD
Levofloxacin—Palpitations—Epirubicin—pancreatic cancer	6.68e-05	0.000205	CcSEcCtD
Levofloxacin—Loss of consciousness—Epirubicin—pancreatic cancer	6.65e-05	0.000204	CcSEcCtD
Levofloxacin—Cough—Epirubicin—pancreatic cancer	6.6e-05	0.000202	CcSEcCtD
Levofloxacin—Vision blurred—Doxorubicin—pancreatic cancer	6.59e-05	0.000202	CcSEcCtD
Levofloxacin—Asthenia—Docetaxel—pancreatic cancer	6.57e-05	0.000201	CcSEcCtD
Levofloxacin—Hypertension—Epirubicin—pancreatic cancer	6.53e-05	0.0002	CcSEcCtD
Levofloxacin—Ill-defined disorder—Doxorubicin—pancreatic cancer	6.49e-05	0.000199	CcSEcCtD
Levofloxacin—Pruritus—Docetaxel—pancreatic cancer	6.47e-05	0.000198	CcSEcCtD
Levofloxacin—Anaemia—Doxorubicin—pancreatic cancer	6.47e-05	0.000198	CcSEcCtD
Levofloxacin—Chest pain—Epirubicin—pancreatic cancer	6.44e-05	0.000197	CcSEcCtD
Levofloxacin—Myalgia—Epirubicin—pancreatic cancer	6.44e-05	0.000197	CcSEcCtD
Levofloxacin—Arthralgia—Epirubicin—pancreatic cancer	6.44e-05	0.000197	CcSEcCtD
Levofloxacin—Agitation—Doxorubicin—pancreatic cancer	6.43e-05	0.000197	CcSEcCtD
Levofloxacin—Anxiety—Epirubicin—pancreatic cancer	6.42e-05	0.000196	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	6.39e-05	0.000196	CcSEcCtD
Levofloxacin—Discomfort—Epirubicin—pancreatic cancer	6.36e-05	0.000195	CcSEcCtD
Levofloxacin—Malaise—Doxorubicin—pancreatic cancer	6.31e-05	0.000193	CcSEcCtD
Levofloxacin—Dry mouth—Epirubicin—pancreatic cancer	6.3e-05	0.000193	CcSEcCtD
Levofloxacin—Vertigo—Doxorubicin—pancreatic cancer	6.29e-05	0.000193	CcSEcCtD
Levofloxacin—Syncope—Doxorubicin—pancreatic cancer	6.28e-05	0.000192	CcSEcCtD
Levofloxacin—Leukopenia—Doxorubicin—pancreatic cancer	6.26e-05	0.000192	CcSEcCtD
Levofloxacin—Diarrhoea—Docetaxel—pancreatic cancer	6.26e-05	0.000192	CcSEcCtD
Levofloxacin—Confusional state—Epirubicin—pancreatic cancer	6.22e-05	0.000191	CcSEcCtD
Levofloxacin—Palpitations—Doxorubicin—pancreatic cancer	6.18e-05	0.000189	CcSEcCtD
Levofloxacin—Anaphylactic shock—Epirubicin—pancreatic cancer	6.17e-05	0.000189	CcSEcCtD
Levofloxacin—Oedema—Epirubicin—pancreatic cancer	6.17e-05	0.000189	CcSEcCtD
Levofloxacin—Loss of consciousness—Doxorubicin—pancreatic cancer	6.15e-05	0.000188	CcSEcCtD
Levofloxacin—Infection—Epirubicin—pancreatic cancer	6.13e-05	0.000188	CcSEcCtD
Levofloxacin—Cough—Doxorubicin—pancreatic cancer	6.11e-05	0.000187	CcSEcCtD
Levofloxacin—Shock—Epirubicin—pancreatic cancer	6.07e-05	0.000186	CcSEcCtD
Levofloxacin—Nervous system disorder—Epirubicin—pancreatic cancer	6.05e-05	0.000185	CcSEcCtD
Levofloxacin—Dizziness—Docetaxel—pancreatic cancer	6.05e-05	0.000185	CcSEcCtD
Levofloxacin—Thrombocytopenia—Epirubicin—pancreatic cancer	6.04e-05	0.000185	CcSEcCtD
Levofloxacin—Hypertension—Doxorubicin—pancreatic cancer	6.04e-05	0.000185	CcSEcCtD
Levofloxacin—Tachycardia—Epirubicin—pancreatic cancer	6.02e-05	0.000184	CcSEcCtD
Levofloxacin—Skin disorder—Epirubicin—pancreatic cancer	6e-05	0.000184	CcSEcCtD
Levofloxacin—Hyperhidrosis—Epirubicin—pancreatic cancer	5.97e-05	0.000183	CcSEcCtD
Levofloxacin—Myalgia—Doxorubicin—pancreatic cancer	5.96e-05	0.000182	CcSEcCtD
Levofloxacin—Chest pain—Doxorubicin—pancreatic cancer	5.96e-05	0.000182	CcSEcCtD
Levofloxacin—Arthralgia—Doxorubicin—pancreatic cancer	5.96e-05	0.000182	CcSEcCtD
Levofloxacin—Anxiety—Doxorubicin—pancreatic cancer	5.94e-05	0.000182	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	5.92e-05	0.000181	CcSEcCtD
Levofloxacin—Discomfort—Doxorubicin—pancreatic cancer	5.89e-05	0.00018	CcSEcCtD
Levofloxacin—Anorexia—Epirubicin—pancreatic cancer	5.88e-05	0.00018	CcSEcCtD
Levofloxacin—Dry mouth—Doxorubicin—pancreatic cancer	5.83e-05	0.000178	CcSEcCtD
Levofloxacin—Vomiting—Docetaxel—pancreatic cancer	5.82e-05	0.000178	CcSEcCtD
Levofloxacin—Rash—Docetaxel—pancreatic cancer	5.77e-05	0.000177	CcSEcCtD
Levofloxacin—Hypotension—Epirubicin—pancreatic cancer	5.77e-05	0.000177	CcSEcCtD
Levofloxacin—Dermatitis—Docetaxel—pancreatic cancer	5.76e-05	0.000177	CcSEcCtD
Levofloxacin—Confusional state—Doxorubicin—pancreatic cancer	5.76e-05	0.000176	CcSEcCtD
Levofloxacin—Headache—Docetaxel—pancreatic cancer	5.73e-05	0.000176	CcSEcCtD
Levofloxacin—Anaphylactic shock—Doxorubicin—pancreatic cancer	5.71e-05	0.000175	CcSEcCtD
Levofloxacin—Oedema—Doxorubicin—pancreatic cancer	5.71e-05	0.000175	CcSEcCtD
Levofloxacin—Infection—Doxorubicin—pancreatic cancer	5.67e-05	0.000174	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.62e-05	0.000172	CcSEcCtD
Levofloxacin—Shock—Doxorubicin—pancreatic cancer	5.62e-05	0.000172	CcSEcCtD
Levofloxacin—Nervous system disorder—Doxorubicin—pancreatic cancer	5.6e-05	0.000172	CcSEcCtD
Levofloxacin—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.59e-05	0.000171	CcSEcCtD
Levofloxacin—Insomnia—Epirubicin—pancreatic cancer	5.58e-05	0.000171	CcSEcCtD
Levofloxacin—Tachycardia—Doxorubicin—pancreatic cancer	5.57e-05	0.000171	CcSEcCtD
Levofloxacin—Skin disorder—Doxorubicin—pancreatic cancer	5.55e-05	0.00017	CcSEcCtD
Levofloxacin—Paraesthesia—Epirubicin—pancreatic cancer	5.54e-05	0.00017	CcSEcCtD
Levofloxacin—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.52e-05	0.000169	CcSEcCtD
Levofloxacin—Dyspnoea—Epirubicin—pancreatic cancer	5.5e-05	0.000169	CcSEcCtD
Levofloxacin—Somnolence—Epirubicin—pancreatic cancer	5.49e-05	0.000168	CcSEcCtD
Levofloxacin—Anorexia—Doxorubicin—pancreatic cancer	5.44e-05	0.000167	CcSEcCtD
Levofloxacin—Nausea—Docetaxel—pancreatic cancer	5.44e-05	0.000166	CcSEcCtD
Levofloxacin—Dyspepsia—Epirubicin—pancreatic cancer	5.43e-05	0.000166	CcSEcCtD
Levofloxacin—Decreased appetite—Epirubicin—pancreatic cancer	5.37e-05	0.000164	CcSEcCtD
Levofloxacin—Hypotension—Doxorubicin—pancreatic cancer	5.34e-05	0.000163	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	5.33e-05	0.000163	CcSEcCtD
Levofloxacin—Fatigue—Epirubicin—pancreatic cancer	5.32e-05	0.000163	CcSEcCtD
Levofloxacin—Constipation—Epirubicin—pancreatic cancer	5.28e-05	0.000162	CcSEcCtD
Levofloxacin—Pain—Epirubicin—pancreatic cancer	5.28e-05	0.000162	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	5.2e-05	0.000159	CcSEcCtD
Levofloxacin—Insomnia—Doxorubicin—pancreatic cancer	5.17e-05	0.000158	CcSEcCtD
Levofloxacin—Paraesthesia—Doxorubicin—pancreatic cancer	5.13e-05	0.000157	CcSEcCtD
Levofloxacin—Dyspnoea—Doxorubicin—pancreatic cancer	5.09e-05	0.000156	CcSEcCtD
Levofloxacin—Feeling abnormal—Epirubicin—pancreatic cancer	5.09e-05	0.000156	CcSEcCtD
Levofloxacin—Somnolence—Doxorubicin—pancreatic cancer	5.08e-05	0.000155	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Epirubicin—pancreatic cancer	5.05e-05	0.000155	CcSEcCtD
Levofloxacin—Dyspepsia—Doxorubicin—pancreatic cancer	5.03e-05	0.000154	CcSEcCtD
Levofloxacin—Decreased appetite—Doxorubicin—pancreatic cancer	4.96e-05	0.000152	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.93e-05	0.000151	CcSEcCtD
Levofloxacin—Fatigue—Doxorubicin—pancreatic cancer	4.92e-05	0.000151	CcSEcCtD
Levofloxacin—Urticaria—Epirubicin—pancreatic cancer	4.9e-05	0.00015	CcSEcCtD
Levofloxacin—Pain—Doxorubicin—pancreatic cancer	4.88e-05	0.00015	CcSEcCtD
Levofloxacin—Constipation—Doxorubicin—pancreatic cancer	4.88e-05	0.00015	CcSEcCtD
Levofloxacin—Body temperature increased—Epirubicin—pancreatic cancer	4.88e-05	0.000149	CcSEcCtD
Levofloxacin—Abdominal pain—Epirubicin—pancreatic cancer	4.88e-05	0.000149	CcSEcCtD
Levofloxacin—Feeling abnormal—Doxorubicin—pancreatic cancer	4.71e-05	0.000144	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.67e-05	0.000143	CcSEcCtD
Levofloxacin—Hypersensitivity—Epirubicin—pancreatic cancer	4.55e-05	0.000139	CcSEcCtD
Levofloxacin—Urticaria—Doxorubicin—pancreatic cancer	4.54e-05	0.000139	CcSEcCtD
Levofloxacin—Abdominal pain—Doxorubicin—pancreatic cancer	4.51e-05	0.000138	CcSEcCtD
Levofloxacin—Body temperature increased—Doxorubicin—pancreatic cancer	4.51e-05	0.000138	CcSEcCtD
Levofloxacin—Asthenia—Epirubicin—pancreatic cancer	4.43e-05	0.000136	CcSEcCtD
Levofloxacin—Pruritus—Epirubicin—pancreatic cancer	4.37e-05	0.000134	CcSEcCtD
Levofloxacin—Diarrhoea—Epirubicin—pancreatic cancer	4.22e-05	0.000129	CcSEcCtD
Levofloxacin—Hypersensitivity—Doxorubicin—pancreatic cancer	4.21e-05	0.000129	CcSEcCtD
Levofloxacin—Asthenia—Doxorubicin—pancreatic cancer	4.1e-05	0.000125	CcSEcCtD
Levofloxacin—Dizziness—Epirubicin—pancreatic cancer	4.08e-05	0.000125	CcSEcCtD
Levofloxacin—Pruritus—Doxorubicin—pancreatic cancer	4.04e-05	0.000124	CcSEcCtD
Levofloxacin—Vomiting—Epirubicin—pancreatic cancer	3.92e-05	0.00012	CcSEcCtD
Levofloxacin—Diarrhoea—Doxorubicin—pancreatic cancer	3.91e-05	0.00012	CcSEcCtD
Levofloxacin—Rash—Epirubicin—pancreatic cancer	3.89e-05	0.000119	CcSEcCtD
Levofloxacin—Dermatitis—Epirubicin—pancreatic cancer	3.89e-05	0.000119	CcSEcCtD
Levofloxacin—Headache—Epirubicin—pancreatic cancer	3.87e-05	0.000118	CcSEcCtD
Levofloxacin—Dizziness—Doxorubicin—pancreatic cancer	3.78e-05	0.000116	CcSEcCtD
Levofloxacin—Nausea—Epirubicin—pancreatic cancer	3.67e-05	0.000112	CcSEcCtD
Levofloxacin—Vomiting—Doxorubicin—pancreatic cancer	3.63e-05	0.000111	CcSEcCtD
Levofloxacin—Rash—Doxorubicin—pancreatic cancer	3.6e-05	0.00011	CcSEcCtD
Levofloxacin—Dermatitis—Doxorubicin—pancreatic cancer	3.6e-05	0.00011	CcSEcCtD
Levofloxacin—Headache—Doxorubicin—pancreatic cancer	3.58e-05	0.00011	CcSEcCtD
Levofloxacin—Nausea—Doxorubicin—pancreatic cancer	3.39e-05	0.000104	CcSEcCtD
